Future Challenges And Treatment Of Staphylococcus Aureus Bacteremia With Emphasis On MRSA
Year: 2010
Type: review
Abstract: Staphylococcus aureus bacteremia (SAB) is an urgent medical problem due to its growing frequency and its poor associated outcome. As healthcare delivery increasingly involves invasive procedures and implantable devices, the number of patients at risk for SAB and its complications is likely to grow. Compounding this problem is the growing prevalence of methicillin-resistant S. aureus (MRSA) and the dwindling efficacy of vancomycin, long the treatment of choice for this pathogen. Despite the recent availability of several new antibiotics for S. aureus, new strategies for treatment and prevention are required for this serious, common cause of human infection.
Source: Future Microbiology
DOI: 10.2217/fmb.10.155
Institutions: Gentofte Hospital, Duke Medical Center, Statens Serum Institut
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W2043939693
